A Genome-Wide CRISPR-Cas9 Loss-of-Function Screening to Identify Host Restriction Factors Modulating Oncolytic Virotherapy.
Muscolini M, Hiscott J, Tassone E
Methods Mol Biol. 2023;2589:379-399. doi: 10.1007/978-1-0716-2788-4_25.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.